Citation Safe vs. Harvey

Harvey is a genuinely capable platform for large firms with the budget and procurement infrastructure to support an enterprise AI deployment — typically involving implementation fees, per-seat training costs, and a sales-led contracting process. It is not designed to compete for a solo practitioner's business, and its pricing structure reflects that: market reporting in 2026 places base-tier enterprise seats in the roughly $1,200/seat/month range, with some reports citing figures as high as $2,000+ for mid-market deployments, plus five- and six-figure implementation and training costs on top of seat fees.

A solo practitioner or small-firm lawyer carries the same Rule 11 exposure, the same malpractice risk, and the same sanctions record as a lawyer at a firm large enough to afford a Harvey deployment — with none of the institutional budget to manage it. Citation Safe's tiers ($12–$199/mo) were built specifically for that gap: a narrower, more focused tool (citation verification, not a full research and drafting platform) at a price point a solo practice can actually justify without a procurement process.

We want to be direct: Harvey and Citation Safe are not really competing for the same budget line or solving the same scope of problem. Harvey is a broad AI platform; we are a specific, deterministic verification layer. A large firm using Harvey for research and drafting still benefits from an independent citation verification pass before filing — the two are complementary, not substitutes, even though they sit at completely different price points.

Consider what it actually takes to become a Harvey customer versus a Citation Safe customer. Harvey involves a sales conversation, contract negotiation, a seat minimum (reportedly around 20 seats on some deals), implementation fees that can run five figures, and an annual commitment — a process that can take weeks or months and requires a firm large enough to justify that overhead. Citation Safe involves creating an account and, for paid tiers, entering a card — a process that takes minutes. That gap is not an accident; it reflects two fundamentally different target buyers and two fundamentally different go-to-market models.

As a firm grows and takes on more institutional clients with formal AI governance requirements, a broader platform like Harvey may eventually make sense for the full range of AI-assisted research and drafting needs. We don't see that as a competitive threat so much as a natural growth path — a firm using Harvey for broad AI research still benefits from an independent, deterministic citation verification layer, and there's no reason a firm can't use both simultaneously, even at very different price points, for the different jobs each is actually built to do.

It's also worth noting that Harvey's own marketing generally emphasizes broad research and drafting capability across many practice areas rather than a specific, published citation accuracy claim, which is consistent with its positioning as a comprehensive platform rather than a specialized verification tool. If citation accuracy specifically, rather than general research capability, is your primary concern, a dedicated verification tool addresses that narrower question more directly than a broad platform built to do many things at once.

Harvey is a genuinely capable enterprise platform priced for Am Law 100 budgets; Citation Safe is a narrower, self-serve tool priced for the solo and small-firm lawyer Harvey was never built to reach.